VEGF 164 Protein 493-MV-005/CF from R&D Systems, a Bio-Techne Brand

Product Specs
ItemVEGF 164 Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $349.00Supplier Page View Company Product Page
Catalog Number493-MV-005/CF
SpeciesMouse
Size5 ug (also 25 ug)
Molecule NameVEGF
FormatLyophilized from a 0.2 µm filtered solution in PBS
Purity>97%, by SDS-PAGE with silver staining
Molecular WeightObserved: 42 kDa, non-reducing conditions
Theoretical: 19.4 kDa (monomer)
ApplicationsBioactivity
Conjugate/TagUnconjugated
Source/Expression SystemSf 21 (baculovirus)-derived Recombinant Mouse VEGF 164 Protein, CF
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
NCBI Full Gene Namevascular endothelial growth factor A
NCBI Gene AliasesMVCD1, VEGF, VPF

Specifications/Features

Available conjugates: Sizes Available: 5 ug (also 25 ug)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate CancerCancer ResearchNovember 14, 2025Katherine C. Murphy, Kelly D. DeMarco, Lin Zhou, Jessica Peura, Hadiya K. Giwa, Yvette Lopez-Diaz, Yu-Jui Ho, Junhui Li, Shi Bai, Karl Simin, et al.cells from C57BL/6 mice were directly exposed to 50ng/mL recombinant murine VEGF from R&D Systems (493-MV-005/CF) in the absence of tumor cell co-culture as a control condition. For CD8+ T cells isolated from MP tumor-bearing

(2) MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T Cell and Immunotherapy Responses in Prostate CancerCancer ResNovember 14, 2025Katherine C. Murphy, Kelly D. DeMarco, Lin Zhou, Jessica Peura, Hadiya K. Giwa, Yvette Lopez-Diaz, Yu-Jui Ho, Junhui Li, Shi Bai, Karl Simin, et al.cells from C57BL/6 mice were directly exposed to 50ng/mL recombinant murine VEGF from R&D Systems (493-MV-005/CF) in the absence of tumor cell co-culture as a control condition. For CD8+ T cells isolated from MP tumor-bearing

(3) MYC and p53 alterations cooperate through VEGF signaling to repress cytotoxic T cell and immunotherapy responses in prostate cancerbioRxiv : the preprint server for biologyJuly 24, 2024Murphy KC, DeMarco KD, Zhou L, Lopez-Diaz Y, Ho YJ, Li J, Bai S, Simin K, Zhu LJ, Mercurio AM, et al.cells from C57BL/6 mice were directly exposed to 50ng/mL recombinant murine VEGF from R&D Systems (493-MV-005/CF) in the absence of tumor cell co-culture as a control condition. T cells were then incubated for 4 hours

(4) Conserved stromal-immune cell circuits secure B cell homeostasis and functionNature immunologyJuly 1, 2023Lütge M, De Martin A, Gil-Cruz C, Perez-Shibayama C, Stanossek Y, Onder L, Cheng HW, Kurz L, Cadosch N, Soneson C, et al.

(5) Mice with endothelial cell-selective adhesion molecule deficiency develop coronary microvascular rarefaction and left ventricle diastolic dysfunctionPhysiological reportsMarch 1, 2023Buncha V, Fopiano KA, Lang L, Williams C, Horuzsko A, Filosa JA, Kapuku G, Bagi Z.

(6) Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated PainInternational journal of biological sciencesJanuary 1, 2023Ma K, Singh G, Wang J, O-Sullivan I, Votta-Velis G, Bruce B, Anbazhagan AN, van Wijnen AJ, Im HJ.

(7) Ras drives malignancy through stem cell crosstalk with the microenvironmentNatureDecember 1, 2022Yuan S, Stewart KS, Yang Y, Abdusselamoglu MD, Parigi SM, Feinberg TY, Tumaneng K, Yang H, Levorse JM, Polak L, et al.

(8) Neuroimmune Responses in a New Experimental Animal Model of Cerebral AspergillosismBioOctober 26, 2022Sullivan BN, Baggett MA, Guillory C, Jones M, Steele C.

(9) Sphingosine 1-phosphate receptor 2 promotes erythrocyte clearance by vascular smooth muscle cells in intraplaque hemorrhage through MFG-E8 productionCellular signallingOctober 1, 2022Pan D, Wu W, Zuo G, Xie X, Li H, Ren X, Kong C, Zhou W, Zhang Z, Waterfall M, et al.

(10) Protective role of VEGF/VEGFR2 signaling against high fatality associated with hepatic encephalopathy via sustaining mitochondrial bioenergetics functionsJournal of biomedical scienceJuly 3, 2022Tsai CY, Wu JCC, Wu CJ, Chan SHH.

(11) Exposure to the Dioxin-like Pollutant PCB 126 Afflicts Coronary Endothelial Cells via Increasing 4-Hydroxy-2 Nonenal: A Role for Aldehyde Dehydrogenase 2ToxicsJune 16, 2022Roy B, Yang Z, Pan G, Roth K, Agarwal M, Sharma R, Petriello MC, Palaniyandi SS.

(12) Gatekeeping role of Nf2/Merlin in vascular tip EC induction through suppression of VEGFR2 internalizationScience advancesJune 10, 2022Bae JH, Yang MJ, Jeong SH, Kim J, Hong SP, Kim JW, Kim YH, Koh GY.

(13) Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesisNature communicationsMay 19, 2022Meçe O, Houbaert D, Sassano ML, Durré T, Maes H, Schaaf M, More S, Ganne M, García-Caballero M, Borri M, et al.

(14) Regeneration of glomerular metabolism and function by podocyte pyruvate kinase M2 in diabetic nephropathyJCI insightMarch 8, 2022Fu J, Shinjo T, Li Q, St-Louis R, Park K, Yu MG, Yokomizo H, Simao F, Huang Q, Wu IH, et al.

(15) Ultraefficient extracellular vesicle-guided direct reprogramming of fibroblasts into functional cardiomyocytesScience advancesFebruary 25, 2022Kim H, Song BW, Park SJ, Choi SW, Moon H, Hwang KC, Kang SW, Moon SH, Yang Y, Kwon IC, et al.

(16) Assessment of mouse VEGF neutralization by ranibizumab and afliberceptPloS oneJanuary 1, 2022Ichiyama Y, Matsumoto R, Obata S, Sawada O, Saishin Y, Kakinoki M, Sawada T, Ohji M.

(17) Platycodon grandiflorum Triggers Antitumor Immunity by Restricting PD-1 Expression of CD8(+) T Cells in Local Tumor MicroenvironmentFrontiers in pharmacologyJanuary 1, 2022Yang R, Pei T, Huang R, Xiao Y, Yan J, Zhu J, Zheng C, Xiao W, Huang C.

(18) Efficient protein incorporation and release by a jigsaw-shaped self-assembling peptide hydrogel for injured brain regenerationNature communicationsNovember 19, 2021Yaguchi A, Oshikawa M, Watanabe G, Hiramatsu H, Uchida N, Hara C, Kaneko N, Sawamoto K, Muraoka T, Ajioka I.

(19) Mitochondrial respiratory chain function promotes extracellular matrix integrity in cartilageThe Journal of biological chemistryOctober 1, 2021Bubb K, Holzer T, Nolte JL, Krüger M, Wilson R, Schlötzer-Schrehardt U, Brinckmann J, Altmüller J, Aszodi A, Fleischhauer L, et al.

(20) The P300/XBP1s/Herpud1 axis promotes macrophage M2 polarization and the development of choroidal neovascularizationJournal of cellular and molecular medicineJuly 1, 2021Li W, Wang Y, Zhu L, Du S, Mao J, Wang Y, Wang S, Bo Q, Tu Y, Yi Q.

Be the First to Write a Review!

VEGF 164 Protein from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (98)

Reviews

VEGF 164 Protein from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map